<DOC>
	<DOC>NCT03084432</DOC>
	<brief_summary>The primary objective was to determine whether caffeine therapy is associated with decreases bone mineral content using dual energy x-ray absorptiometry. Secondary objectives were to determine whether caffeine therapy is associated with increased incidence of nephrocalcinosis or bone fracture.</brief_summary>
	<brief_title>Effect of Caffeine on Preterm Infants' Bone Mineral Content</brief_title>
	<detailed_description />
	<mesh_term>Bone Diseases, Metabolic</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Preterm infants with gestational age of 34 weeks or less consecutively admitted to the neonatal intensive care unit Renal or endocrinal diseases Congenital anomalies Suspected chromosomal aberrations Receiving diuretics or steroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>caffeine</keyword>
	<keyword>bone mineral content</keyword>
</DOC>